Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine plus liothyronine versus levothyroxine alone in primary hypothyroidism
IRCT20200410047012N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary hypothyroidism (PH) comparing Levothyroxine + placebo with Levothyroxine + liothyronine (2 arms). Primary endpoint: Change in quality of life. Started Mar 2020; status: completed.
02
Drugs
levothyroxine sodiumliothyronine
03
Conditions
primary hypothyroidism (PH)
Beyond the preview
Go deeper on IRCT20200410047012N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200410047012N1.